Stay updated on Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FEAailxwuY3WQCNzlPIuq8_x_WVY.uncropped.jpg&w=3840&q=75)
Latest updates to the Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial page
- ChecktodayNo Change Detected
- CheckyesterdayNo Change Detected
- Check3 days agoChange DetectedThe study has expanded to include 176 locations and has been updated from revision v2.9.7 to v2.10.0.SummaryDifference0.2%
- Check5 days agoNo Change Detected
- Check6 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.0%
- Check24 days agoChange DetectedThe value of the publication has been updated to include new findings related to the preservation of quality of life in patients with HER2-positive metastatic breast cancer treated with tucatinib or placebo in combination with trastuzumab and capecitabine, as well as intracranial efficacy and survival data from the HER2CLIMB trial.SummaryDifference0.0%
- Check25 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the webpage content.SummaryDifference0.0%
- Check30 days agoChange DetectedThe value of Revision: v2.9.3 has been updated to Revision: v2.9.5, indicating a recent change in the webpage content related to the study details of a clinical trial for HER2+ breast cancer treatment with tucatinib, capecitabine, and trastuzumab.SummaryDifference0.0%
- Check31 days agoChange DetectedThe value of Revision: v2.9.1 has been updated to Revision: v2.9.3, indicating a recent change in the version of the web page content.SummaryDifference0.0%
Stay in the know with updates to Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial page.